19.70
-0.30
(-1.50%)
At close: January 10 at 4:00:00 PM EST
19.45
-0.25
(-1.27%)
After hours: January 10 at 6:44:21 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
Operating Cash Flow
-65,727.00
-28,081.00
-6,458.00
Investing Cash Flow
-206,801.00
3,840.00
-5,068.00
Financing Cash Flow
229,493.00
156,720.00
19,850.00
End Cash Position
35,235.00
140,953.00
8,474.00
Capital Expenditure
--
-56.00
-5,068.00
Issuance of Capital Stock
231,820.00
162,291.00
20,000.00
Issuance of Debt
--
--
250.00
Repayment of Debt
--
--
-400.00
Free Cash Flow
-65,729.00
-28,137.00
-11,526.00
12/31/2022 - 5/7/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PHVS Pharvaris N.V.
17.80
-3.99%
UPB Upstream Bio, Inc.
13.70
-15.38%
ZURA Zura Bio Limited
2.1600
-0.23%
SYRE Spyre Therapeutics, Inc.
22.46
-6.49%
VRDN Viridian Therapeutics, Inc.
18.20
-4.96%
MLTX MoonLake Immunotherapeutics
46.32
-3.85%
CTNM Contineum Therapeutics, Inc.
13.29
-0.60%
MBX MBX Biosciences, Inc.
13.69
-5.65%
COGT Cogent Biosciences, Inc.
7.84
-3.33%
DSGN Design Therapeutics, Inc.
4.5200
-10.94%